Snowball logo
logo
AGYT

Allergy Therapeutics plc

AGYTF • PINK
$0.15$0.00  (0%)
Estimate
EPS
-0.01
Beta
0.924
About the company
Ticker
AGYTF
ISIN
Country
United Kingdom
Sector (GICS)
Healthcare
Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, and offers treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics products. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Synbiotics, and Acarovac Plus. It also develops Grass MATA MPL, a subcutaneous allergen-specific immunotherapy candidate that aims to address the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen; and VLP Peanut, a short-course peanut allergy vaccine. Allergy Therapeutics plc was founded in 1998 and is headquartered in Worthing, the United Kingdom.

Frequently asked questions

What sector does Allergy Therapeutics plc (AGYTF) operate in?

Allergy Therapeutics plc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Allergy Therapeutics plc (AGYTF) current stock price?

As of the latest data, Allergy Therapeutics plc stock price is $0.15, with a previous close of $0.15.

What is Allergy Therapeutics plc (AGYTF) current market capitalization?

Allergy Therapeutics plc market cap is approximately 949.88 million.

What is Allergy Therapeutics plc (AGYTF) Earnings Per Share (EPS)?

The trailing EPS is -$0.01.

Does Allergy Therapeutics plc (AGYTF) pay dividends?

No. Allergy Therapeutics plc does not pay a dividend.

What is Allergy Therapeutics plc (AGYTF) beta (volatility) score?

Allergy Therapeutics plc has a beta of 0.924, meaning its volatility is roughly in line with the market.